At the heart of equitable healthcare lies a critical truth: representation matters.  BlackDoctor.org spoke with Dr. Adrelia ...

If passed, this will materially expand corporate criminal liability, making companies effectively vicariously liable for the conduct of their "senior" employees.

Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it As demand for trial sites increases, more investigators are overburdened or experiencing burnout.

Together, these burdens and concerns related to affordability create financial toxicity for clinical trial participants and are recognized as an issue in cancer care more generally. Financial toxicity ...

Eli Lilly, BMS, Sanofi and Genentech said they're still working to advance clinical trial diversity even as Trump works feverishly to undermine DEI.

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or explanation.

Rising costs and a boom in obesity trials and AI are some of the predicted trends for the clinical trial industry in 2025.

The time is now to align on a shared plan of action as a country to achieve diversity, equity, inclusion, and access in US clinical trials.

Potential buyers of clinical trial sites must understand the complex legal and regulatory challenges involved, such as corporate practice of medicine rules.

The Italian Supreme Court recently stated that the director’s criminal liability cannot automatically trigger the recognition of corporate criminal liability, as company’s organizational fault ...

Innovations in clinical artificial intelligence are pushing boundaries at an incredible rate, but legal and ethical frameworks that govern the use of these technologies are not keeping pace.